易成新能(300080.SZ):部分董事及高管擬增持不低於22萬股公司股份
格隆匯9月11日丨易成新能(300080.SZ)公佈,公司董事長王安樂先生,董事王少峯先生,副總裁楊國新先生,總工程師周雲輝先生,財務總監楊帆先生,黨委副書記、紀委書記、工會主席宋紅偉先生,副總裁蘭曉龍先生、楊光傑先生,副總裁、董事會祕書常興華先生,副總裁崔強先生,共10人計劃自2023年9月12日起6個月內,以自有資金通過深圳證券交易所繫統以集中競價交易的方式增持公司股份,合計增持股份數量不低於22萬股(其中:王安樂先生、王少峯先生每人增持不低於30,000股,其餘8人每人增持不低於20,000股)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.